Invention Grant
- Patent Title: Immunotherapy for reversing immune suppression
- Patent Title (中): 免疫治疗逆转免疫抑制
-
Application No.: US10280627Application Date: 2002-10-26
-
Publication No.: US07731945B2Publication Date: 2010-06-08
- Inventor: John W. Hadden
- Applicant: John W. Hadden
- Applicant Address: US NY New York
- Assignee: Immuno-Rx, Inc.
- Current Assignee: Immuno-Rx, Inc.
- Current Assignee Address: US NY New York
- Agency: Kohn & Associates, PLLC
- Main IPC: A61K45/00
- IPC: A61K45/00 ; A61K47/00

Abstract:
A method for overcoming immune suppression includes the steps of inducing production of naïve T cells and restoring T cell immunity. A method of vaccine immunotherapy includes the steps of inducing production of naïve T cells and exposing the naïve T cells to endogenous or exogenous antigens at an appropriate site. Additionally, a method for unblocking immunization at a regional lymph node includes the steps of promoting differentiation and maturation of immature dendritic cells at a regional lymph node and allowing presentation of processed peptides by resulting mature dendritic cells, thus, for example, exposing tumor peptides to T cells to gain immunization of the T cells. Further, a method of treating cancer and other persistent lesions includes the steps of administering an effective amount of a natural cytokine mixture as an adjuvant to endogenous or exogenous administered antigen to the cancer or other persistent lesions; preferably the natural cytokine mixture is administered in combination with thymosin α1.
Public/Granted literature
- US20030124136A1 Immunotherapy for reversing immune suppression Public/Granted day:2003-07-03
Information query